Display options
Share it on

Proc Natl Acad Sci U S A. 2000 Aug 01;97(16):9168-73. doi: 10.1073/pnas.150079597.

The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q.

Proceedings of the National Academy of Sciences of the United States of America

A Borkhardt, S Bojesen, O A Haas, U Fuchs, D Bartelheimer, I F Loncarevic, R M Bohle, J Harbott, R Repp, U Jaeger, S Viehmann, T Henn, P Korth, D Scharr, F Lampert

Affiliations

  1. Departments of General Pediatrics, Hematology, and Oncology, and Pathology, University of Giessen, D-35392-Giessen, Germany.

PMID: 10908648 PMCID: PMC16840 DOI: 10.1073/pnas.150079597

Abstract

We have isolated the human GRAF gene (for GTPase regulator associated with the focal adhesion kinase pp125(FAK)). This gene was fused with MLL in a unique t(5;11)(q31;q23) that occurred in an infant with juvenile myelomonocytic leukemia. GRAF encodes a member of the Rho family of the GTPase-activating protein (GAP) family. On the protein level, it is 90% homologous to the recently described chicken GRAF gene that functions as a GAP of RhoA in vivo and is thus a critical component of the integrin signaling transduction pathway. The particular position of the human GRAF gene at 5q31 and the proposed antiproliferative and tumor suppressor properties of its avian homologue suggest that it also might be pathogenetically relevant for hematologic malignancies with deletions of 5q. To investigate this possibility, we sequenced 4-5 individual cDNA clones from 13 cases in which one allele of GRAF was deleted. We found point mutations within the GAP domain of the second GRAF allele in one patient. In two additional patients we found an insertion of 52 or 74 bp within the GRAF cDNA that generates a reading frame shift followed by a premature stop codon. GRAF maps outside the previously defined commonly deleted 5q31 region. Nevertheless, inactivation of both alleles in at least some cases suggests that deletions and mutations of the GRAF gene may be instrumental in the development and progression of hematopoeitic disorders with a del(5q).

References

  1. Semin Hematol. 1999 Oct;36(4 Suppl 7):59-72 - PubMed
  2. Cancer Res. 1994 May 1;54(9):2327-30 - PubMed
  3. Blood. 1992 Oct 1;80(7):1659-65 - PubMed
  4. Genomics. 1994 Feb;19(3):425-32 - PubMed
  5. Nature. 1994 Jun 23;369(6482):684-5 - PubMed
  6. Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10610-4 - PubMed
  7. Blood. 1994 Nov 15;84(10):3253-60 - PubMed
  8. Nature. 1994 Nov 10;372(6502):143-9 - PubMed
  9. Leukemia. 1995 Jan;9(1):210-5 - PubMed
  10. Lancet. 1995 Apr 8;345(8954):902-6 - PubMed
  11. Genes Chromosomes Cancer. 1995 Jun;13(2):75-85 - PubMed
  12. Science. 1995 Sep 1;269(5228):1270-2 - PubMed
  13. Nat Med. 1995 Oct;1(10):1052-6 - PubMed
  14. FASEB J. 1996 Apr;10(5):625-30 - PubMed
  15. Mol Cell Biol. 1996 Jun;16(6):3169-78 - PubMed
  16. Cancer Surv. 1996;27:311-22 - PubMed
  17. Leukemia. 1996 Dec;10(12):1883-90 - PubMed
  18. Cancer Genet Cytogenet. 1997 Mar;94(1):1-7 - PubMed
  19. Blood. 1997 May 15;89(10):3534-43 - PubMed
  20. Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6948-53 - PubMed
  21. Nature. 1997 Aug 14;388(6643):693-7 - PubMed
  22. Genomics. 1997 Oct 1;45(1):88-96 - PubMed
  23. Leukemia. 1998 May;12(5):758-63 - PubMed
  24. Leukemia. 1998 May;12(5):811-22 - PubMed
  25. Nature. 1998 Jul 16;394(6690):295-9 - PubMed
  26. Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12254-9 - PubMed
  27. J Cell Sci. 1999 Jan;112 ( Pt 2):231-42 - PubMed
  28. J Cell Biochem Suppl. 1998;30-31:50-4 - PubMed
  29. Leuk Res. 1999 Jul;23(7):677-80 - PubMed
  30. Oncogene. 1999 Jul 1;18(26):3831-45 - PubMed
  31. Br J Haematol. 1999 Sep;106(3):614-26 - PubMed
  32. Science. 1993 Feb 12;259(5097):968-71 - PubMed
  33. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6350-4 - PubMed
  34. Leukemia. 1993 Aug;7 Suppl 2:S34-9 - PubMed
  35. Cancer Surv. 1992;15:143-59 - PubMed
  36. Blood. 1993 Nov 1;82(9):2611-6 - PubMed
  37. Anticancer Res. 1993 Sep-Oct;13(5C):1913-6 - PubMed
  38. Blood. 1994 Jan 1;83(1):5-9 - PubMed
  39. Semin Cancer Biol. 1993 Dec;4(6):387-99 - PubMed
  40. Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2145-50 - PubMed

Substances

MeSH terms

Publication Types